Atezolizumab in the first-line treatment of metastatic non-small cell lung cancer. Clinical experience of the drug application. Case report
Background. Lung cancer is still the leading cause of cancer morbidity and mortality among both men and women. At the same time, non-small cell lung cancer (NSCLC) accounts for 85% of all cases of malignant tumors. Historically, the treatment for locally advanced and metastatic lung cancer was consi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Habib O.N.
2022-04-01
|
| Series: | Современная онкология |
| Subjects: | |
| Online Access: | https://modernonco.orscience.ru/1815-1434/article/viewFile/106844/81221 |